Cardiovascular

Study: New drug effective for ACE-inhibitor angioedema

A Phase II study found that patients with ACE inhibitor-induced angioedema who received ecallantide were more likely to be discharged sooner than those treated with antihistamines and steroids. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares